经气道介入消融治疗周围型肺癌的现状与挑战  

Status and challenges of bronchoscopic ablation in the treatment of peripheral lung cancer

作　　者：钟长镐[1] 李红佳 李时悦[1] Zhong Changhao;Li Hongjia;Li Shiyue(Department of Respiratory and Critical Care Medicine,the First Affiliated Hospital of Guangzhou Medical University,Guangzhou Institute of Respiratory Health,State Key Laboratory of Respiratory Disease,National Clinical Reseach Center for Respiratory Disease,Guangzhou 510120,China)

机构地区：[1]广州医科大学附属第一医院呼吸与危重症医学科、广州呼吸健康研究院、呼吸疾病国家重点实验室、国家呼吸系统疾病临床医学研究中心,广州510120

出　　处：《国际呼吸杂志》2023年第3期288-294,共7页International Journal of Respiration

基　　金：国家重点研发计划(2022YFC2405200);广州市科技重点研发计划项目(202103010001)。

摘　　要：肺癌是全球范围内导致癌症相关死亡的主要原因。肺部介入消融方式为无法行外科手术切除的肺癌患者的综合性治疗提供了新的方式,因其微创、高效、安全、康复快、可重复性强的特点受到临床关注。本文针对经支气管镜方式介入消融治疗周围型肺癌的现状、进展与难点进行了介绍。Lung cancer is the leading cause of cancer-related death worldwide.Pulmonary ablation provides a new approach for the comprehensive treatment in those who cannot be surgically treated.It has been highlighted due to the minimal invasiveness,high-effect,safety and repeatability.This review summarizes the current status,the progress and difficulties of bronchoscopic interventional ablation for peripheral lung cancer.

关 键 词：肺肿瘤 消融技术 支气管镜 冷冻外科手术 

分 类 号：R734.2[医药卫生—肿瘤]